Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hirota

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1982
[Experience with high-dose methotrexate therapy for malignant solid tumors]K Kawai, T Shibata, E Azuma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patientsC H Takimoto, G Morrison, N Harold, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1982
[Experience with high-dose methotrexate therapy for malignant solid tumors]K Kawai, T Shibata, E Azuma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patientsC H Takimoto, G Morrison, N Harold, et al.
Pageof 9